Authorities in Mobile County are urgently searching for a missing mother, her teenage daughter, and toddler son after discovering evidence of a disturbance at their residence, indicating they may have been taken against their will.
President Trump urges immediate House passage of a bipartisan spending deal to end the government shutdown, facing resistance from both progressive Democrats and his own party's right flank over immigration enforcement terms.
The Internal Revenue Service has officially designated a one-time $1,776 payment to approximately 1.5 million U.S. service members as non-taxable income, providing a financial boost that does not need to be reported on federal returns.
The Bureau of Labor Statistics has postponed the release of January's crucial employment data due to a partial government shutdown, leaving markets and policymakers in the dark as a funding impasse in Congress continues.
While a seven-figure nest egg is a common retirement goal, financial experts caution that its sufficiency hinges on withdrawal strategies, lifestyle expectations, and supplemental income.
A new national report reveals Wegmans Food Markets experienced one of the steepest declines in customer satisfaction among major grocers in 2026, as economic pressures reshape shopping priorities toward value and convenience.
Terex Corporation shares gained over 4% following the finalization of its merger with REV Group, creating a diversified specialty equipment giant. The deal is projected to yield $75 million in annual synergies by 2028.
WK Kellogg Co. names former Ferrero executive Jean-Baptiste Santoul as Chief Operating Officer, signaling a strategic shift following its $3.1 billion acquisition by the global confectionery giant.
Asset managers unleashed a historic wave of nearly 1,000 new active ETFs last year, even as a record number shuttered. Despite the high-stakes environment, firms are doubling down, betting on sustained investor demand and advisor adoption to justify the rush.
While many AI stocks soared in 2025, Salesforce shares faced significant headwinds. Despite a challenging year, the cloud software giant's robust fundamentals and reasonable valuation suggest it may be poised for a recovery.
UPS's ambitious free cash flow target for 2026 appears to secure its hefty dividend, but a closer look reveals reliance on asset sales, deep cost cuts, and reduced capital investment—a strategy that may be mortgaging its long-term expansion.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Morgan Stanley's top strategist argues that recent U.S. trade shifts have prompted nations worldwide to reassess and leverage their own economic strengths, creating a multi-year investment opportunity in a more multipolar global order.
A new study reveals the cost gap between Waymo's driverless vehicles and human-driven Uber and Lyft rides is shrinking, signaling a pivotal moment for the competitive robotaxi industry.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
CNBC's Jim Cramer offered a mixed review of ServiceNow, praising its management and cloud platform while expressing deep frustration with the stock's recent performance, calling it a 'nightmare' for investors.
CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
A 65-year-old Thai tourist was killed by a bull elephant with a known history of aggression in Khao Yai National Park, marking the animal's third human fatality and prompting urgent discussions on wildlife management strategies.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
EPAM Systems' stock has surged over 30% in three months, riding a wave of AI optimism. Yet, this rebound contrasts sharply with longer-term declines, leaving investors to weigh if the current price fully reflects future growth or overlooks persistent risks in the IT services sector.
